drugset / Trial / NCT00644917

Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment

NCT00644917 ↗

Phase 1 Completed 38 enrolled Healthpoint
RandomizedSingle-groupQuadruple-blind

Summary

The product is being tested to see if exposure to light causes toxic reactions on the skin.

Timeline

Start
2008-02
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Xenaderm Unknown 20 mg —

Indications

No indication recorded.